Raffaele Napoli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Cardiovascular Risk Factors

Glycemic Control

Top Venues

Diabetes, obesity & metabolism

International journal of molecular sciences

Diabetes/metabolism research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Fulvio Lauretani, Francesco Giallauria, Crescenzo Testa, Claudia Zinni, Beatrice Lorenzi, Irene Zucchini, Marco Salvi, Raffaele Napoli, Marcello Giuseppe Maggio
Dopamine Pharmacodynamics: New Insights. International journal of molecular sciences 25 (10) (2024)
Fulvio Lauretani, Francesco Giallauria, Crescenzo Testa, Claudia Zinni, Beatrice Lorenzi, Irene Zucchini, Marco Salvi, Raffaele Napoli, Marcello Giuseppe Maggio
Dopamine Pharmacodynamics: New Insights. International journal of molecular sciences 25 (10) (2024)
Raffaele Napoli, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Riccardo Candido, null null
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study. Diabetes, obesity & metabolism 26 (9) (2024)
Raffaele Napoli, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Riccardo Candido, null null
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study. Diabetes, obesity & metabolism (2024)
Raffaele Napoli, Cesare Berra, Andrei-Mircea Catarig, Chiara Di Loreto, Emily Donatiello, Tina Landsvig Berentzen, Dario Pitocco, Francesco Giorgino
Once-weekly semaglutide use in patients with type 2 diabetes: real-world data from the SURE Italy observational study. Diabetes, obesity & metabolism (2023)
Raffaele Napoli, Cesare Berra, Andrei-Mircea Catarig, Chiara Di Loreto, Emily Donatiello, Tina Landsvig Berentzen, Dario Pitocco, Francesco Giorgino
Once-weekly semaglutide use in patients with type 2 diabetes: Real-world data from the SURE Italy observational study. Diabetes, obesity & metabolism (2023)
Immacolata Prevenzano, Alessia Leone, Michele Longo, Antonella Nicolò, Serena Cabaro, Francesca Collina, Iacopo Panarese, Gerardo Botti, Pietro Formisano, Raffaele Napoli, Francesco Beguinot, Claudia Miele, Cecilia Nigro
Glyoxalase 1 knockdown induces age-related β-cell dysfunction and glucose intolerance in mice. EMBO reports 23 (7) (2022)
Luca Parrillo, Rosa Spinelli, Mattia Costanzo, Pasqualina Florese, Serena Cabaro, Antonella Desiderio, Immacolata Prevenzano, Gregory Alexander Raciti, Ulf Smith, Claudia Miele, Pietro Formisano, Raffaele Napoli, Francesco Beguinot
Epigenetic Dysregulation of the Homeobox A5 ( HOXA5 ) Gene Associates with Subcutaneous Adipocyte Hypertrophy in Human Obesity. Cells 11 (4) (2022)
Nicola Tecce, Vincenzo Guardasole, Maria Cristina Rotondo, Margherita Matarazzo, Claudia Miele, Raffaele Napoli
Vascular smooth muscle cell dysfunction in patients with hemochromatosis. Internal and emergency medicine (2022)
Raffaele Napoli
Diabetes and Covid-19: An interplay difficult to dissect. Diabetes/metabolism research and reviews 37 (1) (2020)